09 Sep 2024 09:00 à 09:30 Colloque Non enregistré Opening speech Hugues de Thé, Lise Alter & Matthieu Resche-Rigon Premier symposium international THEMA Saint-Louis sur la leucémie 09 Sep 2024 09:00 à 09:30 Partager Facebook Linkedin Copier le lien Flux RSS Audiovisuel
Lundi 9 septembre 2024 Amphithéâtre Marguerite de Navarre, Site Marcelin Berthelot En libre accès, dans la limite des places disponibles 09:00 - 09:30 Intervenant(s) Hugues de Thé Professeur du Collège de France Lise Alter Matthieu Resche-Rigon Événements Précédent Colloque 09 Sep 2024 09:00 à 09:30 Hugues de Thé, Lise Alter & Matthieu Resche-Rigon Opening speech Non enregistré Colloque 09 Sep 2024 09:30 à 09:50 Andreas Trumpp Therapy Response and Resistance of AML Stem Cells to Venetoclax Colloque 09 Sep 2024 10:00 à 10:20 Andrew Lane Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling Colloque 09 Sep 2024 10:30 à 10:50 Alexandre Puissant Overcoming Therapy Resistance in Acute Myeloid Leukemia Colloque 09 Sep 2024 11:10 à 11:40 Nina Cabezas Regulation of Hematopoietic Stem Cell Dormancy Colloque 09 Sep 2024 11:40 à 12:00 Lina Benajiba Unmasking Myeloproliferative Neoplasms Transformation Paths Colloque 09 Sep 2024 12:05 à 12:30 Clemens Schmitt AML State-Switched Non enregistré Colloque 09 Sep 2024 14:30 à 14:55 Marc Raaijmakers Deconstructing Niche Contributions to Disease Pathogenesis and Drug Resistance in AML Colloque 09 Sep 2024 14:55 à 15:20 Diana Passaro Unveil the Role of the Bone Marrow Vascular Niche in Acute Leukemia Non enregistré Colloque 09 Sep 2024 15:20 à 15:40 David Michonneau Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immun… Colloque 09 Sep 2024 16:00 à 16:20 Emmanuel Raffoux Words from patients Colloque 09 Sep 2024 16:20 à 16:45 Courtney DiNardo AML Therapy in 2024: increasingly individualized approaches Colloque 09 Sep 2024 16:45 à 17:05 Olivier Kosmider VEXAS Syndrome in 2024 Colloque 09 Sep 2024 17:05 à 17:30 Régis Peffault de Latour Paroxysmal Nocturnal Hemoglobinuria as an Original Non-Malignant Clonal Expansion Modulated by Compl… Colloque 10 Sep 2024 09:00 à 09:25 Lars Velten Tracking Human Hematopoietic Stem Cell Clones in Health and Disease Colloque 10 Sep 2024 09:25 à 09:50 Emmanuelle Clappier Genomic and Clinical Heterogeneity within Adult Acute Lymphoblastic Leukemia Colloque 10 Sep 2024 09:50 à 10:15 Guillaume Andrieu From Metabolic Vulnerabilities to Targeted Therapies in Leukemia Colloque 10 Sep 2024 10:15 à 10:40 Anindita Roy Developmental Origins of Childhood Leukemia: why does it matter? Colloque 10 Sep 2024 11:00 à 11:25 Timothy Ley AML: Lessons from the Genome Non enregistré Colloque 10 Sep 2024 11:25 à 11:50 Ruud Delwel Targeting Evil Enhancers and Genes in AML Colloque 10 Sep 2024 11:50 à 12:20 Raphael Itzykson Targeting Cystine Import in AML Colloque 10 Sep 2024 13:50 à 14:15 Keisuke Ito Mitochondrial Contributions to Hematopoietic Homeostasis and the Pathogenesis of Hematological Disor… Colloque 10 Sep 2024 14:15 à 14:40 Bethan Psaila Targeting Microenvironmental Drivers of Blood Malignancies Non enregistré Colloque 10 Sep 2024 14:40 à 15:10 Lionel Adès Any Crosstalk in the Treatment of AML and HR-MDS Colloque 10 Sep 2024 15:30 à 15:50 Marie Sebert Clonal Evolution of Genetic Predisposition to Hematological Malignancies Colloque 10 Sep 2024 15:50 à 16:15 Domitille Rérolle PML Unravels New Insights into the Bases of AML Chemotherapy Response Colloque 10 Sep 2024 16:15 à 16:40 Paresh Vyas Clonal Haemopoiesis: stem cell dynamics and stem cell response to inflammation Suivant Voir aussi Hugues de Thé, chaire Oncologie cellulaire et moléculaire Premier symposium international THEMA Saint-Louis sur la leucémie
Colloque 09 Sep 2024 09:00 à 09:30 Hugues de Thé, Lise Alter & Matthieu Resche-Rigon Opening speech Non enregistré
Colloque 09 Sep 2024 09:30 à 09:50 Andreas Trumpp Therapy Response and Resistance of AML Stem Cells to Venetoclax
Colloque 09 Sep 2024 10:00 à 10:20 Andrew Lane Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling
Colloque 09 Sep 2024 10:30 à 10:50 Alexandre Puissant Overcoming Therapy Resistance in Acute Myeloid Leukemia
Colloque 09 Sep 2024 11:40 à 12:00 Lina Benajiba Unmasking Myeloproliferative Neoplasms Transformation Paths
Colloque 09 Sep 2024 14:30 à 14:55 Marc Raaijmakers Deconstructing Niche Contributions to Disease Pathogenesis and Drug Resistance in AML
Colloque 09 Sep 2024 14:55 à 15:20 Diana Passaro Unveil the Role of the Bone Marrow Vascular Niche in Acute Leukemia Non enregistré
Colloque 09 Sep 2024 15:20 à 15:40 David Michonneau Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immun…
Colloque 09 Sep 2024 16:20 à 16:45 Courtney DiNardo AML Therapy in 2024: increasingly individualized approaches
Colloque 09 Sep 2024 17:05 à 17:30 Régis Peffault de Latour Paroxysmal Nocturnal Hemoglobinuria as an Original Non-Malignant Clonal Expansion Modulated by Compl…
Colloque 10 Sep 2024 09:00 à 09:25 Lars Velten Tracking Human Hematopoietic Stem Cell Clones in Health and Disease
Colloque 10 Sep 2024 09:25 à 09:50 Emmanuelle Clappier Genomic and Clinical Heterogeneity within Adult Acute Lymphoblastic Leukemia
Colloque 10 Sep 2024 09:50 à 10:15 Guillaume Andrieu From Metabolic Vulnerabilities to Targeted Therapies in Leukemia
Colloque 10 Sep 2024 10:15 à 10:40 Anindita Roy Developmental Origins of Childhood Leukemia: why does it matter?
Colloque 10 Sep 2024 13:50 à 14:15 Keisuke Ito Mitochondrial Contributions to Hematopoietic Homeostasis and the Pathogenesis of Hematological Disor…
Colloque 10 Sep 2024 14:15 à 14:40 Bethan Psaila Targeting Microenvironmental Drivers of Blood Malignancies Non enregistré
Colloque 10 Sep 2024 15:30 à 15:50 Marie Sebert Clonal Evolution of Genetic Predisposition to Hematological Malignancies
Colloque 10 Sep 2024 15:50 à 16:15 Domitille Rérolle PML Unravels New Insights into the Bases of AML Chemotherapy Response
Colloque 10 Sep 2024 16:15 à 16:40 Paresh Vyas Clonal Haemopoiesis: stem cell dynamics and stem cell response to inflammation
